Member Info for alfista

To some extent you may be right, but we can't foresee when the regulatory approvals, and then the launch of major new products in the vast China market, will appear. That, more than domestic performance, should be the nig driver of renewed interest here IMHO

Poor Naz.
Wouldn't want your world.

I guess they needed the extra .9 m2 for the dustbin?

'Tevva

The extra task of maintaining body temperature is stressful on the cardio function. Having smoother bloodflow, and less aggravated platelets, will logically be a benefit to health.
Can't see anything controversial in telling the world that fact.

Bless, maybe you'll feel better tomorrow.

That's when Dawson met Stephen, bringing Fruitflow to Provexis.

You've been told about the share pricing so many times, it's hard to believe you are not just a wind up merchant.

Welly, I agree, if Provexis are to stand alone as the seller of Fruitflow, then the trumpet has to be blown much louder, and more frequently.

I appreciate none of us can say for sure.
We've seen a change of tack since the update, just hope it doesn't go on too long. Have added a bit, with more funds in reserve.

So .78 is the Buy price, another chunky Sell on Aquis.
Still suspicious gix.

Well done on buying shares before the company existed Jimmy, that's quite a feat !

Perhaps you're calculating the BH order potential twice, since I think that's what was referred to in the update. But, if there are other non China brands ready to launch, that alone could be multiples as you describe.
As for the By Health orders, with a target market of 4-500 million consumers, I think volumes could be much higher that your estimate, but that may be countered by lower margins.

Only musing, it's for each to make their own decisions, as ever.

BTW, does anyone suspect that we are seeing DSMV slowly exiting?

And we already know what they will contain.

Read the last update,
Please.

Don't see any genuine reason to visit and abuse others on this board. Nobody is making such claims. However, there are quite a few who are in profit by having a low average, with the obvious prospect of making proper returns once the project truly delivers in consumer markets IMHO

You must have a lot more respect for the work of journalism than I do.
My late friend described them as "kiddie scribblers", often with very good justification.

Just how long is that piece of string ?
It's an imponderable, but, as the AA will lapse, it may be indicated in future reports how much of the cake PXS received. Or it may not, disclosure would give clues to others tied in with DSM.
Production is outsourced, and production quantities have been ordered for Fruitflow+ before, so no worries in that respect. Logistics outsourcing should be equally straightforward. Sales and marketing to drive up sales, persuading larger brands to come on board is a major challenge. As you say welly, SAMR approval, followed by volume orders from By Health, would provide the basis for global expansion of marketing reach.
What will happen to DSMV in their new, merged, mega company? Another imponderable, but I see no reason for a fire sale, they still retain an important collaboration with the new, standalone, Provexis.

Bella. I won't continue this circular discussion. I believe everyone can appreciate that, if this company gets ALL the profit, it can't be a loss situation,

Bella.
I buy and sell things for a living.
If DSM supplied the product, and made a margin on the cost price, of course that would make the product more expensive to Provexis. DSM gave back a share of that profit, but kept the rest of the profit for themselves.
Now, Provexis will buy from source, therefore the profit will be much greater, not less. We are gaining, not losing.
Basic logic.

The Thread you are posting on is titled?